Armata Pharmaceuticals, Inc. Quarterly Return On Equity in % from Q3 2014 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Armata Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from Q3 2014 to Q3 2024.
  • Armata Pharmaceuticals, Inc. Return On Equity for the quarter ending September 30, 2024 was 89.1 %.
  • Armata Pharmaceuticals, Inc. annual Return On Equity for 2023 was 9.65K %.
  • Armata Pharmaceuticals, Inc. annual Return On Equity for 2022 was -75.2 %, a 9.29% increase from 2021.
  • Armata Pharmaceuticals, Inc. annual Return On Equity for 2021 was -82.9 %, a 0.46% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 89.1 +454 Jul 1, 2024 Sep 30, 2024
Q2 2024 182 +302 Apr 1, 2024 Jun 30, 2024
Q1 2024 389 +497 Jan 1, 2024 Mar 31, 2024
Q4 2023 9.65K +9.73K Oct 1, 2023 Dec 31, 2023
Q3 2023 -365 -294 -419% Jul 1, 2023 Sep 30, 2023
Q2 2023 -120 -48.1 -67% Apr 1, 2023 Jun 30, 2023
Q1 2023 -108 -32.5 -42.8% Jan 1, 2023 Mar 31, 2023
Q4 2022 -75.2 +7.7 +9.29% Oct 1, 2022 Dec 31, 2022
Q3 2022 -70.3 +19.9 +22.1% Jul 1, 2022 Sep 30, 2022
Q2 2022 -71.9 +18.9 +20.9% Apr 1, 2022 Jun 30, 2022
Q1 2022 -75.9 +8.48 +10.1% Jan 1, 2022 Mar 31, 2022
Q4 2021 -82.9 +0.38 +0.46% Oct 1, 2021 Dec 31, 2021
Q3 2021 -90.2 -11.5 -14.6% Jul 1, 2021 Sep 30, 2021
Q2 2021 -90.8 -1.77 -1.99% Apr 1, 2021 Jun 30, 2021
Q1 2021 -84.4 +9.36 +9.99% Jan 1, 2021 Mar 31, 2021
Q4 2020 -83.2 +48.1 +36.6% Oct 1, 2020 Dec 31, 2020
Q3 2020 -78.7 +93.2 +54.2% Jul 1, 2020 Sep 30, 2020
Q2 2020 -89 +81.3 +47.7% Apr 1, 2020 Jun 30, 2020
Q1 2020 -93.7 +123 +56.7% Jan 1, 2020 Mar 31, 2020
Q4 2019 -131 +24.9 +15.9% Oct 1, 2019 Dec 31, 2019
Q3 2019 -172 -95 -123% Jul 1, 2019 Sep 30, 2019
Q2 2019 -170 -108 -172% Apr 1, 2019 Jun 30, 2019
Q1 2019 -216 -130 -149% Jan 1, 2019 Mar 31, 2019
Q4 2018 -156 -54.8 -54% Oct 1, 2018 Dec 31, 2018
Q3 2018 -76.9 +145 +65.4% Jul 1, 2018 Sep 30, 2018
Q2 2018 -62.5 +132 +67.8% Apr 1, 2018 Jun 30, 2018
Q1 2018 -86.8 +48.6 +35.9% Jan 1, 2018 Mar 31, 2018
Q4 2017 -101 +27.7 +21.5% Oct 1, 2017 Dec 31, 2017
Q3 2017 -222 -147 -194% Jul 1, 2017 Sep 30, 2017
Q2 2017 -194 -169 -660% Apr 1, 2017 Jun 30, 2017
Q1 2017 -135 -222 -257% Jan 1, 2017 Mar 31, 2017
Q4 2016 -129 -124 -2303% Oct 1, 2016 Dec 31, 2016
Q3 2016 -75.5 -89.9 -623% Jul 1, 2016 Sep 30, 2016
Q2 2016 -25.6 -403 -107% Apr 1, 2016 Jun 30, 2016
Q1 2016 86.3 +690 Jan 1, 2016 Mar 31, 2016
Q4 2015 -5.38 +204 +97.4% Oct 1, 2015 Dec 31, 2015
Q3 2015 14.4 +153 Jul 1, 2015 Sep 30, 2015
Q2 2015 378 Apr 1, 2015 Jun 30, 2015
Q1 2015 -604 Jan 1, 2015 Mar 31, 2015
Q4 2014 -209 Oct 1, 2014 Dec 31, 2014
Q3 2014 -138 Jul 1, 2014 Sep 30, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.